News
CILcare won FACCNE’s 2023 Women in Business award!
CILcare’s team is honored to have been awarded by the French-American Chamber of New England (FACCNE) in the Women in Business category. The French-American Business Awards took place during FACCNE's annual gala, which has been celebrating for over 20 years the best...
CILcare announces the launch of the OrgaEar project with SATT AxLR and the University of Montpellier
Sylvie PUCHEU, CILcare’s Chief Scientific Officer and Philippe NERIN, SATT AxLR’s PresidentMontpellier - France – May 17th, 2023 – CILcare, a company specialized in the research and development of new therapies for auditory pathologies, and SATT AxLR are launching the...
CILCARE NOMINATED BY FACCNE FOR WOMEN IN BUSINESS AWARD 2023 !
CILcare’s team is honored and delighted to be part of the nominees for Women in Business Award by the French-American Chamber of New England (FACCNE). In one night only, FACCNE groups its Annual Gala and Awards Ceremony to recognize Excellence, Innovation and...
CILcare to speak at the Future of Hearing Healthcare conference
Ototoxicity resulting in inner ear damage is a leading cause of acquired hearing loss worldwide. About a billion people are at risk of avoidable hearing loss, according to the World Health Organization (WHO). This could be minimized or avoided by early testing of...
Watch CILcare’s presentations on ototoxicity at the SPS Northeast Regional Meeting
Join CILcare and our partner CBSET at the Safety Pharmacology Society Northeast Regional Meeting, April 28, from 8:00 AM to 4:00 PM, at Takeda Cambridge, 125 Binney Street, Cambridge, Massachusetts. Lise Byelyayeva, Associate Director, Business Development, will be...
CILcare to present on inner ear therapeutics at the 3rd ISIET Symposium
Susanna Malmström, PhD, Alliances Director, will be in Marrakech on April 28-30, 2023 at the Third International Symposium of the International Society for Inner Ear Therapeutics. Key opinion leaders and experts from the field like Christine Petit, Charles Liberman,...
CILcare expands its Scientific Advisory Board to accelerate its research projects in synaptopathy, an early marker of age-related diseases
Montpellier, France, March 13 2023 – CILcare, a company specialized in the R&D of novel therapies for hearing disorders, has the immense pleasure of welcoming four renown researchers in the field of hearing to its Scientific Advisory Board (SAB): Keith Darrow,...
Join CILcare at ARO’s 2023 Midwinter Meeting
CILcare's team will be in Orlando, FL, to take part in ARO's Midwinter Meeting on February 11-15, 2023. The Association for Research in Otolaryngology (ARO) is an international hearing and vestibular research society that gathers universities, medical centers,...
